Global Intranasal Drug & Vaccine Delivery Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Intranasal Drug & Vaccine Delivery Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global intranasal drug & vaccine delivery market has been segmented on the basis of product outlook, dosage, application, distribution channel, as well as regions and countries.
Nasal administration is a route of administration in which drugs/vaccines are insufflated through the nose. It can be a form of either topical or systematic administration, as the drugs thus locally delivered can go on to have either purely local or systemic effects.
In light of the recent COVID-19 outbreak, there has been a significant surge in the number of key industry players developing various nasal drug delivery innovations for administration to combat the effects of the virus. This crucial factor, along with the increasing prevalence of neurological and respiratory diseases, as well as a spike in the number of intranasal new product launches are some of the primary factors that are expected to fuel the revenue growth of the global intranasal drug & vaccine delivery market in the foreseeable future.
The surging number of prescriptions for non-invasive drug delivery routes to treat chronic diseases such as allergies, rhinitis, among other central nervous system diseases, as well as the growing preference for insufflate products are other factors slated to have a positive impact on the future revenue growth of this global market. The increasing number of chronic diseases across the globe is further contribute to market growth of this industry in the years to come.
Segmentation of the global intranasal drug & vaccine delivery market is as follows:
In terms of product, the liquid delivery devices segment accounted for the majority revenue shares of the global intranasal drug & vaccine delivery market in 2019. This can be attributed to the various types of formulations available for use with these types of devices. The segment for powder delivery devices is also slated to index considerable revenue growth over the coming years due to the fact that high dose concentrations can be administered using this type of device when compared to liquid delivery devices.
On the basis of dosage, the multi-dose spray pumps segment accounted for the majority revenue share of this global market in 2019, due to increased convenience, safety and cost-effectiveness of these devices. However, the single-dose segment is expected to register the fastest rate of revenue growth over the next decade, due to the fact that vaccine formulations, which are presently under development, will be made available in this form of dosage.
With respect to distribution channel, the retail pharmacies segment accounted for the maximum number of revenue shares of this global market in 2019. Although, the online pharmacies segment is anticipated to register the fastest rate of revenue growth over the next decade, due to the various discounts being offered by manufacturers to promote the wholesale purchase of essential drug delivery devices.
And, concerning the application aspect of this market, the respiratory disorders segment accounted for the largest number of revenue shares of this global market in 2019, owing to the implementation of intranasal devices to treat a host of respiratory diseases.
Regional Segmentation and Analysis:
North America accounted for the majority revenue shares of the global intranasal drug & vaccine delivery market in 2019, owing to a rise in the number of FDA approvals for these devices as well as increasing demand for nasal drug delivery devices.
Markets in the APAC region are expected to index the fastest rate of revenue growth over the next 10 years, due to the increase in the number of new market players in this region, improved product development protocols and higher disposable incomes.
Segmentation of the Global Intranasal Drug & Vaccine Delivery Cabinet Market:
Segmentation by Product Outlook:
- Powder Delivery Device
- Liquid Delivery Device
- Pressurized Metered Dose Inhaler
Segmentation by Dosage:
Segmentation by Application:
- Respiratory Disorders
- Neurological Disorder
- Pain Management
Segmentation by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Segmentation by Region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- GlaxoSmithKline Plc
- Teva Pharmaceuticals
- Aptar Pharma
- UCB Inc.
- Teleflex Corporation
- OptiNose Inc.
- Intersect ENT
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!